Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Estrogen elevates the peak overnight production rate of acylated ghrelinRemberto C Paulo, Richard Brundage, Mihaela Cosma, et al.Pharmaceutical Statistics|July 11, 2020
Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidismCynthia Basu, Xiaoye Ma, May Mo, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 18, 2019
Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor TherapyMinjee Kim, Janice K Laramy, Gautham Gampa, et al.Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantationHyewon Kim, Janel Long-Boyle, Nancy Rydholm, et al.AIDS (London, England)|March 8, 2005
An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected childrenAkihiko Saitoh, Kumud K Singh, Christine A Powell, et al.Journal of the Endocrine Society|January 20, 2022
Bone Age Maturation and Growth Outcomes in Young Children with CAH Treated with Hydrocortisone SuspensionHeba Al-Rayess, O Yaw Addo, Elise Palzer, et al.Antimicrobial Agents and Chemotherapy|October 6, 2010
Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteersJennifer J Kiser, J Brock Bumpass, Amie L Meditz, et al.Journal of Clinical Pharmacology|July 19, 2008
Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantationL'Aurelle Johnson, Paul J Orchard, K Scott Baker, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver diseaseRolland C Dickson, Norah A Terrault, Michael Ishitani, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2016
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioningKinjal Sanghavi, Anthony Wiseman, Mark N Kirstein, et al.Pageof 3